SCHEMBL25638991

SCHEMBL25638991

COCC(=O)NC12CCC(C(N)=O)(CC1)CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.41
▸ HSD11B2 P80365 2/20 0.41
▸ ATF4 P18848 3/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ATM Q13315 1/20 0.32
▸ OPRK1 P41145 1/20 0.31
▸ PTGFR P43088 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ THRB P10828 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ HPGD P15428 1/20 0.30
▸ JAK2 O60674 1/20 0.30
▸ JAK1 P23458 1/20 0.30
▸ TYK2 P29597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25639001 0.84 PKM (0.39) ATF4NPSR1ALDH1A1MEN1MAPT
SCHEMBL25638989 0.80 HSD11B1 (0.40) HSD11B1HSD11B2ATF4MEN1KMT2A
SCHEMBL25638992 0.74 ATF4 (0.59) HSD11B1HSD11B2ATF4ALDH1A1MEN1
SCHEMBL2824301 0.71 HSD11B1 (0.41) HSD11B1HSD11B2PTGFRPKM
SCHEMBL22874208 0.70 CHRM1 (0.40) HSD11B1HSD11B2ATF4NPSR1ALDH1A1
SCHEMBL23879650 0.69 HSD11B1 (0.47) HSD11B1HSD11B2MEN1KMT2APTGFR
SCHEMBL20789345 0.69 HSD11B1 (0.41) HSD11B1HSD11B2PTGFRPKM
SCHEMBL4093471 0.69 PKM (0.39) HSD11B1HSD11B2NPSR1MAPTKMT2A
SCHEMBL26550828 0.68 CHRM1 (0.41) HSD11B1ATF4NPSR1ALDH1A1MEN1
SCHEMBL20809501 0.68 HSD11B1 (0.38) HSD11B1HSD11B2KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192712-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192712-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 HSD11B1 229/4885HSD11B2 298/4885ATF4 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback